Scientific Articles

  1. Cohen JP. (2012). Overcoming regulatory and economic challenges facing pharmacogenomics. N Biotechnol 29(6):751-756.
  2. Cooper DN, Chen JM, Ball EV, Howells K, Mort M, Phillips AD, Chuzhanova N, Krawczak M, Kehrer-Sawatzki H, Stenson PD. (2010). Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics. Hum Mutat 31(6):631-655.
  3. Ku CS, Cooper DN, Roukos DH. (2012). The 'sequence everything' approach and personalized clinical decision challenges. Expert Rev Mol Diagn 12(4):319-322.
  4. Patrinos GP, Brookes AJ. (2005). DNA, diseases and databases: disastrously deficient. Trends Genet 21(6):333-338.
  5. Patrinos GP. (2006). National and ethnic mutation databases: recording populations' genography. Hum Mutat 27(9):879-887.
  6. Prainsack B, Vayena E. (2013). Beyond the clinic: 'direct-to-consumer' genomic profiling services and pharmacogenomics. Pharmacogenomics 14(4):403-412.
  7. Syurina EV, Brankovic I, Probst-Hensch N, Brand A. (2011). Genome-based health literacy: a new challenge for public health genomics. Public Health Genomics 14(4-5):201-210.
  8. Vayena E, Gourna E, Streuli J, Hafen E, Prainsack B. (2012). Experiences of early users of direct-to-consumer genomics in Switzerland: an exploratory study. Public Health Genomics 15(6):352-362.
  9. Patrinos GP, Baker DJ, Al-Mulla F, Vasiliou V, Cooper DN. (2013). Genetic tests obtainable through pharmacies: The good the bad and the ugly. Hum Genomics 7:17.
Home Publications Scientific Articles

You can find us


145 -157 St John Street, London, EC1V 4PW, UK

Tel: +44-(0)207-608.51.91,
E-mail: gma(AT)goldenhelix{DOT}org